{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inborn+Errors+of+Metabolism&page=58", "query": { "condition": "Inborn Errors of Metabolism", "page": 58 }, "page_size": 10 }, "pagination": { "page": 58, "page_size": 10, "total_count": 1605, "total_pages": 161, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inborn+Errors+of+Metabolism&page=59&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inborn+Errors+of+Metabolism&page=57&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-19T20:21:52.727Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06674109", "title": "SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Gout and Hyperuricemia" ], "interventions": [ { "name": "Empagliflozin 10 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 60, "start_date": "2026-07-01", "completion_date": "2028-02-28", "has_results": false, "last_update_posted_date": "2026-08-05", "last_synced_at": "2026-10-19T20:21:52.727Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06674109" }, { "nct_id": "NCT04193592", "title": "Efficacy and Safety of Pirfenidone Treatment in HPS-ILD", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hermansky Pudlak Syndrome", "Interstitial Lung Disease" ], "interventions": [ { "name": "Pirfenidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jesse Roman", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 50, "start_date": "2019-12-01", "completion_date": "2022-12-31", "has_results": false, "last_update_posted_date": "2019-12-10", "last_synced_at": "2026-10-19T20:21:52.727Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04193592" }, { "nct_id": "NCT00925301", "title": "Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Fabry Disease" ], "interventions": [ { "name": "migalastat hydrochloride", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amicus Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "16 Years to 74 Years" }, "enrollment_count": 67, "start_date": "2009-10-23", "completion_date": "2014-01-29", "has_results": true, "last_update_posted_date": "2018-10-30", "last_synced_at": "2026-10-19T20:21:52.727Z", "location_count": 13, "location_summary": "Los Angeles, California • San Francisco, California • Decatur, Georgia + 10 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Decatur", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00925301" }, { "nct_id": "NCT01873911", "title": "Neurobehavioral Phenotypes in MPS III", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Sanfilippo Syndrome Type A", "Sanfilippo Syndrome Type B", "Hurler Syndrome" ], "interventions": [], "intervention_types": [], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "2 Years to 12 Years" }, "enrollment_count": 30, "start_date": "2010-12", "completion_date": "2014-08", "has_results": false, "last_update_posted_date": "2019-11-01", "last_synced_at": "2026-10-19T20:21:52.727Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01873911" }, { "nct_id": "NCT00472732", "title": "Neurologic Injuries in Adults With Urea Cycle Disorders", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Brain Diseases, Metabolic, Inborn", "Urea Cycle Disorder", "Ornithine Transcarbamylase Deficiency" ], "interventions": [], "intervention_types": [], "sponsor": "Andrea Gropman", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 46, "start_date": "2007-03", "completion_date": "2010-07", "has_results": true, "last_update_posted_date": "2015-06-24", "last_synced_at": "2026-10-19T20:21:52.727Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00472732" }, { "nct_id": "NCT05040373", "title": "Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hereditary Transthyretin-mediated (hATTR) Amyloidosis", "Polyneuropathy" ], "interventions": [], "intervention_types": [], "sponsor": "Alnylam Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 10, "start_date": "2020-08-01", "completion_date": "2030-10-12", "has_results": false, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-10-19T20:21:52.727Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT05040373" }, { "nct_id": "NCT02135705", "title": "LOWER: Lomitapide Observational Worldwide Evaluation Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Homozygous Familial Hypercholesterolemia" ], "interventions": [ { "name": "Lomitapide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amryt Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 260, "start_date": "2014-03-18", "completion_date": "2026-04-27", "has_results": false, "last_update_posted_date": "2026-05-12", "last_synced_at": "2026-10-19T20:21:52.727Z", "location_count": 46, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Cottonwood, Arizona + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Cottonwood", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02135705" }, { "nct_id": "NCT01586871", "title": "Carotid Structure and Function in MPS Syndromes: A Multicenter Study of the Lysosomal Disease Network", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Mucopolysaccharidoses" ], "interventions": [], "intervention_types": [], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Years to 18 Years" }, "enrollment_count": 1147, "start_date": "2012-03", "completion_date": "2017-06", "has_results": true, "last_update_posted_date": "2021-02-24", "last_synced_at": "2026-10-19T20:21:52.727Z", "location_count": 2, "location_summary": "Orange, California • Minneapolis, Minnesota", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01586871" }, { "nct_id": "NCT00302146", "title": "Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parkinson Disease", "Gaucher Disease" ], "interventions": [ { "name": "15-0 H20", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Human Genome Research Institute (NHGRI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "110 Years", "sex": "ALL", "summary": "18 Years to 110 Years" }, "enrollment_count": 64, "start_date": "2006-05-23", "completion_date": null, "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-19T20:21:52.727Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00302146" }, { "nct_id": "NCT06451757", "title": "KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Mitochondrial Diseases", "Maternally Inherited Diabetes and Deafness (MIDD)", "Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)", "Mitochondrial DNA tRNALeu(UUR) m.3243A